{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:22:14Z","timestamp":1780392134398,"version":"3.54.1"},"reference-count":67,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1001\/jamacardio.2020.2855","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T15:01:35Z","timestamp":1596034895000},"page":"1286","source":"Crossref","is-referenced-by-count":2,"title":["Influence of Clinical Trials of Acute Coronary Syndrome Beyond the Primary Hypothesis"],"prefix":"10.1001","volume":"5","author":[{"given":"Leiah M.","family":"Luoma","sequence":"first","affiliation":[{"name":"Canadian Virtual Coordinating Centre for Global Collaborative Cardiovascular Research, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Westerhout","sequence":"additional","affiliation":[{"name":"Canadian Virtual Coordinating Centre for Global Collaborative Cardiovascular Research, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Canadian Virtual Coordinating Centre for Global Collaborative Cardiovascular Research, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"15","key":"hrv200005r1","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jacc.2015.03.016","article-title":"Cardiovascular drug development: is it dead or just hibernating?","volume":"65","author":"Fordyce","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hrv200005r2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.","volume":"297","author":"Armstrong","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"hrv200005r3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ahj.2006.06.006","article-title":"Reflections on early stopping of a clinical trial.","volume":"152","author":"Armstrong","year":"2006","journal-title":"Am Heart J"},{"issue":"6","key":"hrv200005r4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cct.2008.06.003","article-title":"Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.","volume":"29","author":"Mahaffey","year":"2008","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"hrv200005r5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurheartj\/ehi138","article-title":"Guidelines for percutaneous coronary interventions.","volume":"26","author":"Silber","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"hrv200005r6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2005.12.001","article-title":"ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (ACC\/AHA\/SCAI Writing Committee to update the 2001 guidelines for percutaneous coronary intervention).","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hrv200005r7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol."},{"issue":"13","key":"hrv200005r8","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"issue":"2","key":"hrv200005r9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","article-title":"2007 Focused update of the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"51","author":"Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hrv200005r10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jacc.2007.10.002","article-title":"2007 Focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice guidelines.","volume":"51","author":"King","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"hrv200005r11","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.","volume":"29","author":"Van de Werf","year":"2008","journal-title":"Eur Heart J"},{"issue":"23","key":"hrv200005r12","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","article-title":"2009 Focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"54","author":"Kushner","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"hrv200005r13","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization.","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"issue":"23","key":"hrv200005r14","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"issue":"19","key":"hrv200005r15","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.jacc.2011.02.011","article-title":"2011 ACCF\/AHA focused update incorporated into the ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol."},{"issue":"24","key":"hrv200005r16","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention.","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"hrv200005r17","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","article-title":"2011 ACCF\/AHA focused update of the guidelines for the management of patients with unstable angina\/non-ST\u2013elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hrv200005r18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","article-title":"2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"60","author":"Jneid","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"hrv200005r19","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"issue":"23","key":"hrv200005r20","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.jacc.2013.01.014","article-title":"2012 ACCF\/AHA focused update incorporated into the ACCF\/AHA 2007 guidelines for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"61","author":"Anderson","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hrv200005r21","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines.","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"hrv200005r22","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"37","key":"hrv200005r23","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J."},{"issue":"10","key":"hrv200005r24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","article-title":"2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction.","volume":"67","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hrv200005r25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation of the European Society of Cardiology (ESC).","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"hrv200005r26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"hrv200005r27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jama.293.4.427","article-title":"Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.","volume":"293","author":"Yusuf","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"hrv200005r28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jama.293.4.437","article-title":"Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"issue":"12","key":"hrv200005r29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"hrv200005r30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.","volume":"26","author":"Malmberg","year":"2005","journal-title":"Eur Heart J"},{"issue":"11","key":"hrv200005r31","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).","volume":"45","author":"Ross","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hrv200005r32","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes.","volume":"353","author":"de Winter","year":"2005","journal-title":"N Engl J Med"},{"issue":"9497","key":"hrv200005r33","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"issue":"9497","key":"hrv200005r34","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"issue":"9510","key":"hrv200005r35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(06)68147-6","article-title":"Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.","volume":"367","author":"Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators","year":"2006","journal-title":"Lancet"},{"issue":"13","key":"hrv200005r36","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"issue":"13","key":"hrv200005r37","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"issue":"20","key":"hrv200005r38","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1001\/jama.298.20.2399","article-title":"Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.","volume":"298","author":"D\u00edaz","year":"2007","journal-title":"JAMA"},{"issue":"14","key":"hrv200005r39","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa060898","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.","volume":"354","author":"Antman","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"hrv200005r40","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes.","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"issue":"21","key":"hrv200005r41","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes.","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"hrv200005r42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"issue":"16","key":"hrv200005r43","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non\u2013ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"issue":"20","key":"hrv200005r44","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"hrv200005r45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMoa0706416","article-title":"Thrombus aspiration during primary percutaneous coronary intervention.","volume":"358","author":"Svilaas","year":"2008","journal-title":"N Engl J Med"},{"issue":"19","key":"hrv200005r46","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.","volume":"360","author":"Stone","year":"2009","journal-title":"N Engl J Med"},{"issue":"21","key":"hrv200005r47","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction.","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"issue":"21","key":"hrv200005r48","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","article-title":"Facilitated PCI in patients with ST-elevation myocardial infarction.","volume":"358","author":"Ellis","year":"2008","journal-title":"N Engl J Med"},{"issue":"21","key":"hrv200005r49","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes.","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"issue":"21","key":"hrv200005r50","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes.","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"issue":"26","key":"hrv200005r51","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1056\/NEJMoa0808276","article-title":"Routine early angioplasty after fibrinolysis for acute myocardial infarction.","volume":"360","author":"Cantor","year":"2009","journal-title":"N Engl J Med"},{"issue":"9692","key":"hrv200005r52","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0140-6736(09)61454-9","article-title":"Otamixaban for the treatment of patients with non-ST\u2013elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.","volume":"374","author":"Sabatine","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"hrv200005r53","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"hrv200005r54","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI.","volume":"361","author":"Bhatt","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"hrv200005r55","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI.","volume":"361","author":"Harrington","year":"2009","journal-title":"N Engl J Med"},{"key":"hrv200005r56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canep.2018.06.005","article-title":"The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.","volume":"55","author":"Unger","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"hrv200005r57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jclinepi.2019.09.012","article-title":"Twenty percent of secondary publications of randomized controlled trials of drugs did not provide new results relative to the primary publication.","volume":"117","author":"Lai","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"18","key":"hrv200005r58","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1001\/jama.2019.2994","article-title":"Postpublication metrics of randomized clinical trials with and without null findings.","volume":"321","author":"Murray","year":"2019","journal-title":"JAMA"},{"issue":"8","key":"hrv200005r59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002292","article-title":"Publication speed, reporting metrics, and citation impact of cardiovascular trials supported by the National Heart, Lung, and Blood Institute.","volume":"4","author":"Gordon","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"hrv200005r60","doi-asserted-by":"publisher","first-page":"i637","DOI":"10.1136\/bmj.i637","article-title":"Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers.","volume":"352","author":"Chen","year":"2016","journal-title":"BMJ"},{"key":"hrv200005r61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jclinepi.2016.05.016","article-title":"Randomized trials are frequently fragmented in multiple secondary publications.","volume":"79","author":"Ebrahim","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"hrv200005r62","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jamaoncol.2015.6487","article-title":"The scientific impact of positive and negative phase 3 cancer clinical trials.","volume":"2","author":"Unger","year":"2016","journal-title":"JAMA Oncol"},{"issue":"9","key":"hrv200005r63","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1161\/CIRCULATIONAHA.110.989772","article-title":"Evaluating research in cardiovascular medicine: citation counts are not sufficient.","volume":"123","author":"McAlister","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"hrv200005r64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jtcvs.2010.08.035","article-title":"Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials.","volume":"142","author":"Smith","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"hrv200005r65","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMp1605260","article-title":"Sharing data from cardiovascular clinical trials\u2014a proposal.","volume":"375","author":"Patel","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"hrv200005r66","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jchf.2018.02.003","article-title":"Traveling the interstices of data sharing.","volume":"6","author":"Armstrong","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"14","key":"hrv200005r67","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/eurheartj\/ehq129","article-title":"Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.","volume":"31","author":"Toma","year":"2010","journal-title":"Eur Heart J"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2768901\/jamacardiology_luoma_2020_rv_200005_1605207411.21509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T17:02:09Z","timestamp":1605718929000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2768901"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2020.2855","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}